Targeted Cancer Therapies
Conjugated Proteins
Combination Therapies and Personalized Medicine
Phase II Conjugation Reactions: Overview
Tumor Immunotherapy
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Yu Zhang1, Pan He2, Peng Zhang1
1Key Laboratory of Polymer Ecomaterials, Jilin Biomedical Polymers Engineering Laboratory, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, P. R. China.
Polypeptides-drug conjugates offer improved cancer treatment by enhancing drug delivery and reducing side effects. This review highlights advances in designing these conjugates for better therapeutic outcomes.
09:09Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery
Published on: June 23, 2020
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: